Business Context and Reporting Period
This Form 8-K filing by Herbalife Ltd. reports a significant capital market transaction occurring on February 7, 2014, with an additional issuance on February 12, 2014. The company, incorporated in the Cayman Islands, executed a private placement of convertible debt to qualified institutional buyers under Rule 144A.
Key Financial Metrics and Transaction Details
- Total Debt Issued: $1.15 billion aggregate principal amount of 2.00% Convertible Senior Notes due 2019 (comprising $1.0 billion Base Notes and $150 million Option Notes).
- Interest Rate: 2.00% per annum, payable semiannually in cash starting August 15, 2014.
- Maturity Date: August 15, 2019.
- Conversion Price: Approximately $86.28 per common share (initial conversion rate of 11.5908 shares per $1,000 principal).
- Transaction Costs: Approximately $124 million paid for capped call transactions and approximately $686 million paid for prepaid forward share repurchase transactions.
- Underwriter Discounts: Approximately $25.9 million.
Material Changes and Transaction Structure
The filing details the creation of a direct financial obligation through the issuance of the Notes. To manage potential dilution and facilitate investor hedging, Herbalife entered into two key derivative arrangements:
- Capped Call Transactions: Funded with approximately $124 million to cover the number of shares underlying the Notes, intended to reduce dilution upon conversion in excess of the principal amount.
- Prepaid Forward Share Repurchase Transactions: Funded with approximately $686 million to purchase approximately 9.9 million common shares for settlement near the Notes' maturity. These transactions are expected to facilitate derivative transactions between counterparties and investors.
Outlook, Risks, and Contingencies
The Notes are convertible into cash up to their principal amount and common shares for any excess conversion value. Holders may convert freely on or after May 15, 2019. Prior to this date, conversion is permitted only under specific conditions, such as the stock price exceeding 130% of the conversion price for a specified period or the trading price of the Notes falling below 98% of the product of the stock price and conversion rate. In the event of a "fundamental change," holders may require Herbalife to repurchase the Notes at 100% of the principal amount plus accrued interest. The Notes and underlying shares are unregistered under the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the impact of the $1.15 billion debt issuance on the company's leverage ratios and liquidity position.
- Confirm the settlement terms and potential share count adjustments for the 9.9 million shares purchased via prepaid forward transactions.
- Monitor the stock price relative to the $86.28 conversion price to assess the likelihood of early conversion or dilution.
- Review the specific definitions of "fundamental change" in the Indenture to understand repurchase triggers.